IVF/ICSI周期中增殖期内膜的全周期分子分析可预测新鲜胚胎移植结局
本研究嵌套于一项随机对照试验,对18例在卵巢刺激期获取的增殖期内膜活检进行转录组分析,未发现活产与着床失败组间显著差异基因表达;但分离培养的子宫内膜基质细胞分泌组在两组间差异显著,提示增殖期内膜功能评估或可预测同一周期新鲜胚胎移植结局。
要点
- 全组织内膜转录组未显示活产与着床失败组间显著差异基因表达。
- 内膜基质细胞分泌组在两组间形成清晰聚类,可区分临床结局。
- 体外蜕膜化后两组分泌组差异减弱,提示细胞因子谱趋同。
核心结论
- 全组织内膜转录组与新鲜胚胎移植结局无显著差异基因表达关联。
- 分离培养的内膜基质细胞分泌组可区分活产与着床失败患者。
研究设计与样本
- 嵌套于一项研究卵巢刺激早期卵泡期内膜搔刮对IVF/ICSI临床妊娠率影响的随机对照试验。
- 从96份内膜活检中经匹配筛选18份样本,比较9例活产与9例着床失败患者。
- 对18份全组织活检行RNA测序,对其中9份子集分离培养内膜基质细胞并体外蜕膜化2天和4天。
- 采用多重悬浮珠免疫分析检测45种细胞因子,并以偏最小二乘回归建模分析。
主要发现
- 多重假设检验校正后,活产组与着床失败组全组织内膜活检间无显著差异基因表达。
- 内膜基质细胞分离培养后分泌组分析显示两个清晰聚类,分别对应两个临床组。
- 体外蜕膜化后分泌组谱从无分化细胞发生偏移,但两组间差异仍存在却减弱,提示蜕膜化后细胞因子谱趋同。
临床怎么用
- 增殖期内膜活检可在不损害同一周期新鲜胚胎移植机会的前提下获取分子信息。
- 内膜功能评估不应仅限于着床窗期,增殖期或可早期检出某些内膜功能障碍。
- 基于内膜基质细胞分泌组的检测有望用于IVF/ICSI结局预测,但需进一步验证。
局限性
- 样本量有限(18份活检,分泌组子集9份)。
- 内膜基质细胞实验为体外性质,需更大规模验证。
- 随机对照试验外增殖期内膜活检可得性极低,验证难以实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does an early proliferative phase endometrial biopsy harvested during ovarian stimulation harbour information predictive of the outcome following fresh embryo transfer (ET) in that same cycle? SUMMARY ANSWER: Transcriptome analysis of the whole-tissue endometrium did not reveal significant differential gene expression (DGE) in relation to the outcome; however, the secretome profile of isolated, cultured and in vitro decidualized endometrial stromal cells (EnSCs) varied significantly between patients who had a live birth compared to those with an implantation failure following fresh ET in the same cycle as the biopsy. WHAT IS KNOWN ALREADY: In the majority of endometrial receptivity research protocols, biopsies are harvested during the window of implantation (WOI). This, however, precludes ET in that same cycle, which is preferable as the endometrium has been shown to adapt over time. Endometrial biopsies taken during ovarian stimulation have been reported not to harm the chances of implantation, and in such biopsies DGE has been observed between women who achieve pregnancy versus those who do not. The impact of the endometrial proliferative phase on human embryo implantation remains unclear, but deserves further attention, especially since in luteal phase endometrial biopsies, a transcriptional signature predictive for repeated implantation failure has been associated with reduced cell proliferation, possibly indicating proliferative phase involvement. Isolation, culture and in vitro decidualization (IVD) of EnSCs is a frequently applied basic research technique to assess endometrial functioning, and a disordered EnSC secretome has previously been linked with failed implantation. STUDY DESIGN, SIZE, DURATION: This study was nested in a randomized controlled trial (RCT) investigating the effect of endometrial scratching during the early follicular phase of ovarian stimulation on clinical pregnancy rates after IVF/ICSI. Of the 96 endometrial biopsies available, after eliminating those without fresh ET and after extensive matching in order to minimize the risk of potential confounding, 18 samples were retained to study two clinical groups: nine biopsies of patients with a live birth versus nine biopsies of patients with an implantation failure, both following fresh ET performed in the same cycle as the biopsy. We studied the proliferative endometrium by analysing its transcriptome and by isolating, culturing and decidualizing EnSCs in vitro. We applied this latter technique for the first time on proliferative endometrial biopsies obtained during ovarian stimulation for in-cycle outcome prediction, in an attempt to overcome inter-cycle variability. PARTICIPANTS/MATERIALS, SETTING, METHODS: RNA-sequencing was performed for 18 individual whole-tissue endometrial biopsies on an Illumina HiSeq1500 machine. DGE was analysed three times using different approaches (DESeq2, EdgeR and the Wilcoxon rank-sum test, all in R). EnSC isolation and IVD was performed (for 2 and 4 days) for a subset of nine samples, after which media from undifferentiated and decidualized cultures were harvested, stored at -80°C and later assayed for 45 cytokines using a multiplex suspension bead immunoassay. The analysis was performed by partial least squares regression modelling. MAIN RESULTS AND THE ROLE OF CHANCE: After correction for multiple hypothesis testing, DGE analysis revealed no significant differences between endometrial samples from patients who had a live birth and those with an implantation failure following fresh ET. However secretome analysis after EnSC isolation and culture, showed two distinct clusters that clearly corresponded to the two clinical groups. Upon IVD, the secretome profiles shifted from that of undifferentiated cells but the difference between the two clinical groups remained yet were muted, suggesting convergence of cytokine profiles after decidualization. LIMITATIONS, REASONS FOR CAUTION: Caution is warranted due to the limited sample size of the study and the in vitro nature of the EnSC experiment. Validation on a larger scale is necessary, however, hard to fulfil given the very limited availability of in-cycle proliferative endometrial biopsies outside a RCT setting. WIDER IMPLICATIONS OF THE FINDINGS: These data support the hypothesis that the endometrium should be assessed not only during the WOI and that certain endometrial dysfunctionalities can probably be detected early in a cycle by making use of the proliferative phase. This insight opens new horizons for the development of endometrial tests, whether diagnostic or predictive of IVF/ICSI treatment outcome. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by Fonds Wetenschappelijk Onderzoek (FWO, Flanders, Belgium, 11M9415N, 1 524 417N), Wetenschappelijk Fonds Willy Gepts (WFWG G160, Universitair Ziekenhuis Brussel, Belgium) and the National Medicine Research Council (NMRC/CG/M003/2017, Singapore). There are no conflicts of interests. TRIAL REGISTRATION NUMBER: NCT02061228.
引用
- Mackens S, Santos-Ribeiro S, Racca A, et al. The proliferative phase endometrium in IVF/ICSI: an in-cycle molecular analysis predictive of the outcome following fresh embryo transfer. Hum Reprod. 2020. PMID: 31916571. doi:10.1093/humrep/dez218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。